SCHEMBL3936384

SCHEMBL3936384

CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)cc(C3(S(=O)(=O)c4ccc(C(N)=O)cc4Cl)CC3)n2)cc1.C[C@H]1COCCN1c1cc(C2(S(=O)(=O)c3ccc(C(N)=O)cc3Cl)CC2)nc(-c2ccc(NC(=O)NC3CC3)cc2)n1

nearest known ligand 0.55

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 9/20 0.55
PIK3CD O00329 7/20 0.55
MTOR P42345 17/20 0.53
PIK3CB P42338 1/20 0.53
PIK3CG P48736 1/20 0.53
RPTOR Q8N122 3/20 0.47
MLST8 Q9BVC4 3/20 0.47
KCNH2 Q12809 1/20 0.47
RICTOR Q6R327 1/20 0.47
MAPKAP1 Q9BPZ7 1/20 0.47
CYP3A4 P08684 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4207709 0.96 PIK3CA (0.54) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL4200493 0.96 PIK3CA (0.60) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL4200189 0.89 MTOR (0.63) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL3924153 0.89 PIK3CA (0.55) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL3932807 0.89 PIK3CA (0.54) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL3927753 0.86 PIK3CA (0.56) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL3931737 0.86 PIK3CA (0.63) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL4207151 0.86 PIK3CA (0.53) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL4203754 0.86 PIK3CA (0.59) PIK3CAPIK3CDMTORPIK3CBPIK3CG
SCHEMBL4204062 0.84 MTOR (0.49) PIK3CAPIK3CDMTORPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074118-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES AstraZeneca AB (SE) 2009-07-01 EP disclosed
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed